These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25165102)

  • 1. Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome.
    Streeck H; Lu R; Beckwith N; Milazzo M; Liu M; Routy JP; Little S; Jessen H; Kelleher AD; Hecht F; Sekaly RP; Alter G; Heckerman D; Carrington M; Rosenberg ES; Altfeld M
    J Virol; 2014 Nov; 88(21):12793-801. PubMed ID: 25165102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
    Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
    J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.
    Radebe M; Gounder K; Mokgoro M; Ndhlovu ZM; Mncube Z; Mkhize L; van der Stok M; Jaggernath M; Walker BD; Ndung'u T
    AIDS; 2015 Jan; 29(1):23-33. PubMed ID: 25387316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
    Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
    Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure.
    Ngumbela KC; Day CL; Mncube Z; Nair K; Ramduth D; Thobakgale C; Moodley E; Reddy S; de Pierres C; Mkhwanazi N; Bishop K; van der Stok M; Ismail N; Honeyborne I; Crawford H; Kavanagh DG; Rousseau C; Nickle D; Mullins J; Heckerman D; Korber B; Coovadia H; Kiepiela P; Goulder PJ; Walker BD
    AIDS Res Hum Retroviruses; 2008 Jan; 24(1):72-82. PubMed ID: 18275350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
    Cao J; McNevin J; Holte S; Fink L; Corey L; McElrath MJ
    J Virol; 2003 Jun; 77(12):6867-78. PubMed ID: 12768006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.
    Leitman EM; Hurst J; Mori M; Kublin J; Ndung'u T; Walker BD; Carlson J; Gray GE; Matthews PC; Frahm N; Goulder PJ
    J Infect Dis; 2016 Aug; 214(3):379-89. PubMed ID: 26951820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between gag-specific CD8 T-cell responses, viral load, and CD4 count in HIV-1 infection is dependent on disease status.
    Jiao Y; Xie J; Li T; Han Y; Qiu Z; Zuo L; Wang A
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):263-8. PubMed ID: 16763520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.
    Kunwar P; Hawkins N; Dinges WL; Liu Y; Gabriel EE; Swan DA; Stevens CE; Maenza J; Collier AC; Mullins JI; Hertz T; Yu X; Horton H
    PLoS One; 2013; 8(5):e64405. PubMed ID: 23741326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point.
    Gray CM; Mlotshwa M; Riou C; Mathebula T; de Assis Rosa D; Mashishi T; Seoighe C; Ngandu N; van Loggerenberg F; Morris L; Mlisana K; Williamson C; Karim SA;
    J Virol; 2009 Jan; 83(1):470-8. PubMed ID: 18945774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection.
    Radebe M; Nair K; Chonco F; Bishop K; Wright JK; van der Stok M; Bassett IV; Mncube Z; Altfeld M; Walker BD; Ndung'u T
    J Infect Dis; 2011 Sep; 204(5):768-76. PubMed ID: 21844303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.
    Cao J; McNevin J; Malhotra U; McElrath MJ
    J Immunol; 2003 Oct; 171(7):3837-46. PubMed ID: 14500685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control.
    Schieffer M; Jessen HK; Oster AF; Pissani F; Soghoian DZ; Lu R; Jessen AB; Zedlack C; Schultz BT; Davis I; Ranasinghe S; Rosenberg ES; Alter G; Schumann RR; Streeck H
    J Virol; 2014 Jul; 88(13):7357-66. PubMed ID: 24741089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection.
    Peng BJ; Carlson JM; Liu MKP; Gao F; Goonetilleke N; McMichael AJ; Borrow P; Gilmour J; Heath SL; Hunter E; Bansal A; Goepfert PA
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute-Phase CD4
    Sutton MS; Ellis-Connell A; Moriarty RV; Balgeman AJ; Gellerup D; Barry G; Weiler AM; Friedrich TC; O'Connor SL
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1-specific CD4(+) responses in primary HIV-1 infection predict disease progression.
    Frater J; Ewings F; Hurst J; Brown H; Robinson N; Fidler S; Babiker A; Weber J; Porter K; Phillips RE;
    AIDS; 2014 Mar; 28(5):699-708. PubMed ID: 24549145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.
    Matthews PC; Koyanagi M; Kløverpris HN; Harndahl M; Stryhn A; Akahoshi T; Gatanaga H; Oka S; Juarez Molina C; Valenzuela Ponce H; Avila Rios S; Cole D; Carlson J; Payne RP; Ogwu A; Bere A; Ndung'u T; Gounder K; Chen F; Riddell L; Luzzi G; Shapiro R; Brander C; Walker B; Sewell AK; Reyes Teran G; Heckerman D; Hunter E; Buus S; Takiguchi M; Goulder PJ
    J Virol; 2012 Dec; 86(23):12643-54. PubMed ID: 22973023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.
    Li W; Li C; Xia W; Li X
    Hum Vaccin Immunother; 2017 Oct; 13(10):2341-2347. PubMed ID: 28771107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.